- Home
- RR vs CADL Comparison
RR vs CADL Comparison
Compare RR & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RR
- CADL
- Stock Information
- Founded
- RR 2016
- CADL 1999
- Country
- RR United States
- CADL United States
- Employees
- RR N/A
- CADL N/A
- Industry
- RR
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- RR
- CADL Health Care
- Exchange
- RR Nasdaq
- CADL Nasdaq
- Market Cap
- RR 337.3M
- CADL 306.4M
- IPO Year
- RR 2023
- CADL 2021
- Fundamental
- Price
- RR $2.22
- CADL $11.63
- Analyst Decision
- RR
- CADL Strong Buy
- Analyst Count
- RR 0
- CADL 4
- Target Price
- RR N/A
- CADL $19.75
- AVG Volume (30 Days)
- RR 15.4M
- CADL 1.2M
- Earning Date
- RR 02-14-2025
- CADL 03-27-2025
- Dividend Yield
- RR N/A
- CADL N/A
- EPS Growth
- RR N/A
- CADL N/A
- EPS
- RR N/A
- CADL N/A
- Revenue
- RR $4,391,000.00
- CADL N/A
- Revenue This Year
- RR N/A
- CADL N/A
- Revenue Next Year
- RR N/A
- CADL N/A
- P/E Ratio
- RR N/A
- CADL N/A
- Revenue Growth
- RR N/A
- CADL N/A
- 52 Week Low
- RR $0.30
- CADL $1.34
- 52 Week High
- RR $5.20
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- RR 42.84
- CADL 72.95
- Support Level
- RR $2.50
- CADL $8.11
- Resistance Level
- RR $3.12
- CADL $13.68
- Average True Range (ATR)
- RR 0.33
- CADL 0.78
- MACD
- RR -0.08
- CADL 0.42
- Stochastic Oscillator
- RR 8.78
- CADL 70.29
About RR Richtech Robotics Inc. Class B
Richtech Robotics Inc is a developer of new robotic technologies focused on transforming labor-intensive services in hospitality and other sectors currently experiencing unprecedented labor shortages. The company designs, manufacture and sells robots to restaurants, hotels, senior living centers, casinos, factories, movie theaters and other businesses. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company designs its robots to be friendly, customizable to client environments, and extremely reliable.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.